Xuefeng Ren

Xuefeng Ren

Auto-generated profile, based on publicly available information

Xuefeng Ren

Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TFThomas G. Flower
Thomas G. Flower
CBCosmo Z. Buffalo
Cosmo Z. Buffalo
RHRichard M. Hooy
Richard M. Hooy
MAMarc Allaire
Marc Allaire
XRXuefeng Ren
Xuefeng Ren
JHJames H. Hurley
James H. Hurley
The molecular basis for the severity and rapid spread of the COVID-19 disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely unknown. ORF8 is a rapidly evolving accessory protein that has been proposed to interfere with immune responses. The crystal structure of SARS-CoV-2 ORF8 was determined at 2.04-Å resolution by X-ray crystallography. The structure reveals a ∼60-residue core similar to SARS-CoV-2 ORF7a, with the addition of two dimerization interfaces unique to SARS-CoV-2 ORF8. A covalent disulfide-linked dimer is formed through an N-terminal sequence specific to SARS-CoV-2, while a separate noncovalent interface is formed by another SARS-CoV-2−specific sequence, 73YIDI76. Together, the presence of these interfaces shows how SARS-CoV-2 ORF8 can form unique large-scale assemblies not possible for SARS-CoV, potentially mediating unique immune suppression and evasion activities. Significance The structure of the SARS-CoV-2 ORF8 protein reveals two novel intermolecular interfaces layered onto an ORF7 fold. One is mediated by a disulfide bond, the other is noncovalent, and both are novel with respect to SARS-CoV. The structural analysis here establishes a molecular framework for understanding the rapid evolution of ORF8, its contributions to COVID-19 pathogenesis, and the potential for its neutralization by antibodies.

21 December 2018 in Science
Verified
Journal Article
Closed access
PDF file
JSJohannes Schöneberg
Johannes Schöneberg
MPMark Remec Pavlin
Mark Remec Pavlin
SYShannon Yan
Shannon Yan
MRMaurizio Righini
Maurizio Righini
ILIl-Hyung Lee
Il-Hyung Lee
JHJames H. Hurley
James H. Hurley
Membrane scission by ESCRTs: The ESCRT protein complexes are essential for cell division, the release of HIV from infected cells via budding, and other cell processes involving the scission of narrow membrane necks from their inner surface. The unusual inside-directed membrane cutting has made it hard to recapitulate this reaction and understand its mechanism. Schöneberg et al. encapsulated ESCRTs inside lipid vesicles and used optical tweezers to pull out membrane nanotubes. In the presence of adenosine triphosphate, clusters of ESCRTs generated force and constricted the nanotube, eventually severing it. This approach provides a window into the molecular mechanisms involved in the activities of ESCRTs. Science , this issue p. 1423

19 October 2022 in Nature
Verified
Journal Article
Open access
PDF file
YLYing Liu
Ying Liu
PXPengbiao Xu
Pengbiao Xu
SRSophie Rivara
Sophie Rivara
CLChong Liu
Chong Liu
JRJonathan Ricci
Jonathan Ricci
AAAndrea Ablasser
Andrea Ablasser
Stimulator of interferon genes (STING) functions downstream of cyclic GMP-AMP synthase in DNA sensing or as a direct receptor for bacterial cyclic dinucleotides and small molecules to activate immunity during infection, cancer and immunotherapy1–10. Precise regulation of STING is essential to ensure balanced immune responses and prevent detrimental autoinflammation11–16. After activation, STING, a transmembrane protein, traffics from the endoplasmic reticulum to the Golgi, where its phosphorylation by the protein kinase TBK1 enables signal transduction17–20. The mechanism that ends STING signalling at the Golgi remains unknown. Here we show that adaptor protein complex 1 (AP-1) controls the termination of STING-dependent immune activation. We find that AP-1 sorts phosphorylated STING into clathrin-coated transport vesicles for delivery to the endolysosomal system, where STING is degraded21. We identify a highly conserved dileucine motif in the cytosolic C-terminal tail (CTT) of STING that, together with TBK1-dependent CTT phosphorylation, dictates the AP-1 engagement of STING. A cryo-electron microscopy structure of AP-1 in complex with phosphorylated STING explains the enhanced recognition of TBK1-activated STING. We show that suppression of AP-1 exacerbates STING-induced immune responses. Our results reveal a structural mechanism of negative regulation of STING and establish that the initiation of signalling is inextricably associated with its termination to enable transient activation of immunity.

1 December 2019 in Journal of Virology
Verified
Journal Article
Closed access
CBCosmo Z. Buffalo
Cosmo Z. Buffalo
YIYuichiro Iwamoto
Yuichiro Iwamoto
JHJames H. Hurley
James H. Hurley
XRXuefeng Ren
Xuefeng Ren
The accessory protein Nef of human immunodeficiency virus (HIV) is a primary determinant of viral pathogenesis. Nef is abundantly expressed during infection and reroutes a variety of cell surface proteins to disrupt host immunity and promote the viral replication cycle. Nef counteracts host defenses by sequestering and/or degrading its targets via the endocytic and secretory pathways. Nef does this by physically engaging a number of host trafficking proteins.

17 February 2023 in Science Advances
Verified
Journal Article
Closed access
XRXuefeng Ren
Xuefeng Ren
TNThanh N. Nguyen
Thanh N. Nguyen
WLWai Kit Lam
Wai Kit Lam
CBCosmo Z. Buffalo
Cosmo Z. Buffalo
MLMichael Lazarou
Michael Lazarou
JHJames H. Hurley
James H. Hurley
The assembly of the autophagy initiation machinery nucleates autophagosome biogenesis, including in the PINK1- and Parkin-dependent mitophagy pathway implicated in Parkinson’s disease. The structural interaction between the sole transmembrane autophagy protein, autophagy-related protein 9A (ATG9A), and components of the Unc-51–like autophagy activating kinase (ULK1) complex is one of the major missing links needed to complete a structural map of autophagy initiation. We determined the 2.4-Å x-ray crystallographic structure of the ternary structure of ATG9A carboxyl-terminal tail bound to the ATG13:ATG101 Hop1/Rev7/Mad2 (HORMA) dimer, which is part of the ULK1 complex. We term the interacting portion of the extreme carboxyl-terminal part of the ATG9A tail the “HORMA dimer–interacting region” (HDIR). This structure shows that the HDIR binds to the HORMA domain of ATG101 by β sheet complementation such that the ATG9A tail resides in a deep cleft at the ATG13:ATG101 interface. Disruption of this complex in cells impairs damage-induced PINK1/Parkin mitophagy mediated by the cargo receptor NDP52.

25 July 2025 in Nature Cell Biology
Verified
Journal Article
Open access
EAElias Adriaenssens
Elias Adriaenssens
SSStefan Schaar
Stefan Schaar
ACAnnan S. I. Cook
Annan S. I. Cook
JSJan F. M. Stuke
Jan F. M. Stuke
JSJustyna Sawa-Makarska
Justyna Sawa-Makarska
SMSascha Martens
Sascha Martens
Selective autophagy is a lysosomal degradation pathway that is critical for maintaining cellular homeostasis by disposing of harmful cellular material. Although the mechanisms by which soluble cargo receptors recruit the autophagy machinery are becoming increasingly clear, the principles governing how organelle-localized transmembrane cargo receptors initiate selective autophagy remain poorly understood. Here we demonstrate that the human transmembrane cargo receptors can initiate autophagosome biogenesis not only by recruiting the upstream FIP200/ULK1 complex but also via a WIPI–ATG13 complex. This latter pathway is employed by the BNIP3/NIX receptors to trigger mitophagy. Additionally, other transmembrane mitophagy receptors, including FUNDC1 and BCL2L13, exclusively use the FIP200/ULK1 complex, whereas FKBP8 and the ER-phagy receptor TEX264 are capable of utilizing both pathways to initiate autophagy. Our study defines the molecular rules for initiation by transmembrane cargo receptors, revealing remarkable flexibility in the assembly and activation of the autophagy machinery, with important implications for therapeutic interventions.